Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing

OBJECTIVES: Several guidelines for the evaluation of laboratory tests for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection have recommended establishing an a priori definition of minimum clinical performance specifications before test selection and method evaluation. METHODS: U...

Descripción completa

Detalles Bibliográficos
Autores principales: Loh, Tze Ping, Lord, Sarah J, Bell, Katy, Bohn, Mary Kathryn, Lim, Chun Yee, Markus, Corey, Fares Taie, Hernan, Adeli, Khosrow, Lippi, Giuseppe, Sandberg, Sverre, Horvath, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678449/
https://www.ncbi.nlm.nih.gov/pubmed/33227233
http://dx.doi.org/10.1016/j.clinbiochem.2020.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678449/
https://www.ncbi.nlm.nih.gov/pubmed/33227233
http://dx.doi.org/10.1016/j.clinbiochem.2020.11.003

Ejemplares similares